Delivery Order SPE2DB24D1007-SPE2DB25FCCXD
Award Date 8/19/25
Potential Completion Date 8/20/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $4,620.72 delivery order to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a small-value transaction within AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jatenzo 237 mg capsules (120 count), with a ceiling value of $2,479.28. This competitive delivery order, issued with firm fixed pricing, represents a non-set-aside award and is scheduled for ultimate completion by August 14, 2025. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a $1,131.88 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Jatenzo 158 mg capsules (120-count unit). This firm fixed-price delivery order, which is a child contract under a larger vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. The award utilized no set-aside designation and was competitively awarded through open...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,253.16 to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 198 mg, a testosterone replacement therapy medication. The contract was competitively awarded without set-aside designation on July 21, 2025, with an ultimate completion date of July 22, 2025. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under firm fixed-price terms and...
- The Defense Logistics Agency awarded a delivery order valued at $1,336.63 to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg, a testosterone replacement therapy medication. The award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, was made without set-aside designation through open competition using firm fixed price contracting. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Jatenzo 198 mg capsules (120 count). This is a firm fixed-price delivery order with a ceiling value of $1,292.51 and an ultimate completion date of July 31, 2025. The contract is not set aside and represents a competitive award to the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $1,209 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 237 mg Jatenzo capsules. Under this order, Amerisourcebergen will deliver 120 capsules to a location in Conshohocken, Pennsylvania by June 23, 2023 to support the Department of Defense. As a leading pharmaceutical distributor, Amerisourcebergen frequently fulfills delivery orders for prescription drugs and medical supplies under the Defense Logistics Agency's Prime Vendor...
- The Defense Logistics Agency awarded a $8,442.15 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Jatenzo 237 mg capsules (120-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 24, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical distributor serving federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,913.33 Firm Fixed Price Delivery Order is for the supply of 120 capsules of the medication JATENZO 237 MG. The contract has an ultimate completion date of May 8, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of pharmaceutical products. The contract, valued at $1,227.52, is for the delivery of 120 capsules of the drug Jatenzo 237 mg. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical...